Avidity Partners Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-94,500	Closed	-$9.86M	–	46
2025 Q2	$9.86M	Buy	94,500 +17,500	+23%	+$1.85M	1.98%	19
2025 Q1	$8.98M	Sell	77,000 -111,000	-59%	-$12.6M	1.85%	20
2024 Q4	$15.9M	Sell	188,000 -108,100	-37%	-$9.94M	1.59%	27
2024 Q3	$26.6M	Sell	296,100 -79,900	-21%	-$6.97M	1.36%	30
2024 Q2	$30.3M	Sell	376,000 -55,000	-13%	-$4.07M	1.29%	30
2024 Q1	$34.4M	Sell	431,000 -28,400	-6%	-$2.38M	1.22%	35
2023 Q4	$36.6M	Buy	459,400 +162,600	+55%	+$10.9M	1.4%	36
2023 Q3	$20.7M	Sell	296,800 -248,200	-46%	-$18.6M	0.84%	47
2023 Q2	$39.2M	Sell	545,000 -74,200	-12%	-$5.47M	1.37%	31
2023 Q1	$38.2M	Sell	619,200 -50,800	-8%	-$3.34M	1.27%	29
2022 Q4	$51.7M	Sell	670,000 -868,600	-56%	-$51.9M	1.21%	30
2022 Q3	$68.7M	Buy	+1,538,600	New	+$76.9M	1.49%	25
2022 Q2	–	Sell	-711,000	Closed	-$29.4M	–	84
2022 Q1	$29.4M	Sell	711,000 -64,000	-8%	-$1.98M	0.65%	43
2021 Q4	$29.3M	Buy	+775,000	New	+$28.5M	0.62%	49
2020 Q4	–	Sell	-118,000	Closed	-$8.41M	–	101
2020 Q3	$8.41M	Sell	118,000 -286,900	-71%	-$22.4M	0.45%	49
2020 Q2	$33.3M	Buy	404,900 +207,900	+106%	+$16M	2.14%	14
2020 Q1	$11.6M	Buy	+197,000	New	+$16.1M	1.66%	24